The Impact of HLA and KIR Ligand Mismatching on Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Korean Adult Patients.
10.3343/alm.2015.35.1.111
- Author:
Hyewon PARK
1
;
Eun Youn RHO
;
Ji Won IN
;
Inho KIM
;
Sung Soo YOON
;
Seonyang PARK
;
Sue SHIN
;
Kyoung Un PARK
;
Eun Young SONG
Author Information
1. Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea. eysong1@snu.ac.kr
- Publication Type:Original Article
- Keywords:
HLA;
KIR ligand;
Mismatch;
Hematopoietic stem cell transplantation
- MeSH:
Adolescent;
Adult;
Alleles;
Female;
Genetic Loci;
Graft vs Host Disease/etiology;
HLA Antigens/*genetics/metabolism;
*Hematopoietic Stem Cell Transplantation/adverse effects/standards;
Histocompatibility Testing;
Humans;
Kaplan-Meier Estimate;
Leukemia/mortality/therapy;
Male;
Middle Aged;
Multivariate Analysis;
Receptors, KIR/*chemistry/metabolism;
Republic of Korea;
Risk Factors;
Transplantation, Homologous;
Young Adult
- From:Annals of Laboratory Medicine
2015;35(1):111-117
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: The impact of HLA and KIR ligand mismatching on the outcome of hematopoietic stem cell transplantation (HSCT) remains unclear. Previous reports have identified considerable ethnic differences in the impact of HLA and KIR ligand mismatches, as well as KIR ligand status, on HSCT; however, to date, no data has been acquired in Korean adult patients. METHODS: We investigated the association of high-resolution HLA matching on five loci (HLA-A, -B, -C, -DRB1, and -DQB1), KIR ligand mismatching, and KIR ligand status on the outcome of allogeneic HSCT from unrelated donors in 154 Korean adult patients treated at Seoul National University Hospital. RESULTS: In a multivariate analysis, less than 9/10 allelic matches in five HLA loci was an independent risk factor for acute graft-versus-host disease (GVHD) (grade II to IV) (P=0.019, odds ratio [OR]=2.7). In addition, HLA-A allele mismatching was increasingly prevalent in patients with acute GVHD compared to patients without (61.9% vs. 34.5%, P=0.06). For KIR ligand status, the patient and donor combination of both C1/C1 ligands showed better event-free and overall survival than combinations with C2 ligand patients or donors (P=0.048, P=0.034, respectively) by log-rank test. CONCLUSIONS: Korean adult transplant patients with less than 9 of 10 HLA allele matches in the HLA-A, -B, -C, -DRB1, and DQB1 loci have a higher likelihood of developing acute GVHD (grade II to IV). Impact of KIR ligand status on clinical outcome should be further studied in a larger patient population.
